Hiroshi Hataya

4.2k total citations
142 papers, 2.0k citations indexed

About

Hiroshi Hataya is a scholar working on Nephrology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Hiroshi Hataya has authored 142 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Nephrology, 33 papers in Surgery and 29 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Hiroshi Hataya's work include Renal Diseases and Glomerulopathies (31 papers), Dialysis and Renal Disease Management (22 papers) and Chronic Kidney Disease and Diabetes (17 papers). Hiroshi Hataya is often cited by papers focused on Renal Diseases and Glomerulopathies (31 papers), Dialysis and Renal Disease Management (22 papers) and Chronic Kidney Disease and Diabetes (17 papers). Hiroshi Hataya collaborates with scholars based in Japan, United States and Australia. Hiroshi Hataya's co-authors include Masataka Honda, Kenji Ishikura, Shuichi Ito, Masahiro Ikeda, Yuko Hamasaki, Osamu Uemura, Naoya Fujita, Takuhito Nagai, Kazumoto Iijima and Tetsuji Kaneko and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Kidney International.

In The Last Decade

Hiroshi Hataya

126 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hiroshi Hataya Japan 23 1.0k 390 351 303 258 142 2.0k
Jayanthi Chandar United States 22 990 1.0× 745 1.9× 489 1.4× 169 0.6× 128 0.5× 70 2.0k
Sanjeev Gulati India 29 1.0k 1.0× 240 0.6× 316 0.9× 365 1.2× 129 0.5× 108 1.9k
Gastón Zilleruelo United States 26 1.0k 1.0× 515 1.3× 386 1.1× 149 0.5× 75 0.3× 76 2.1k
Frank Martinez France 24 782 0.8× 164 0.4× 356 1.0× 551 1.8× 910 3.5× 56 2.2k
Hüseyin Töz Türkiye 26 1.8k 1.8× 158 0.4× 425 1.2× 964 3.2× 285 1.1× 145 3.1k
Paul T. McEnery United States 28 977 1.0× 383 1.0× 459 1.3× 388 1.3× 443 1.7× 64 2.0k
Aydın Türkmen Türkiye 24 478 0.5× 107 0.3× 258 0.7× 490 1.6× 414 1.6× 170 1.8k
C. Frederic Strife United States 29 784 0.8× 464 1.2× 319 0.9× 210 0.7× 91 0.4× 63 1.8k
Ziad Zoghby United States 20 777 0.8× 279 0.7× 580 1.7× 624 2.1× 616 2.4× 60 2.2k
Oğuz Söylemezoğlu Türkiye 22 773 0.8× 233 0.6× 552 1.6× 290 1.0× 90 0.3× 121 1.9k

Countries citing papers authored by Hiroshi Hataya

Since Specialization
Citations

This map shows the geographic impact of Hiroshi Hataya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroshi Hataya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroshi Hataya more than expected).

Fields of papers citing papers by Hiroshi Hataya

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroshi Hataya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroshi Hataya. The network helps show where Hiroshi Hataya may publish in the future.

Co-authorship network of co-authors of Hiroshi Hataya

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroshi Hataya. A scholar is included among the top collaborators of Hiroshi Hataya based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroshi Hataya. Hiroshi Hataya is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hagiwara, Yusuke, et al.. (2025). Procaterol via nebulizer versus metered‐dose inhaler with a spacer for acute asthma exacerbation in children. Pediatrics International. 67(1). e70072–e70072.
2.
Saito, Hiroshi, Shori Takahashi, Riku Hamada, et al.. (2024). Fractional excretion of total protein in patients with nephrotic syndrome. Pediatrics International. 66(1). 2 indexed citations
3.
Hamada, Riku, Ryoko Harada, Yuko Hamasaki, et al.. (2024). Sodium removal per ultrafiltration volume in automated peritoneal dialysis in pediatric patients. Pediatric Nephrology. 39(9). 2753–2758.
4.
Hamada, Riku, Yoshihiko Morikawa, Ryoko Harada, et al.. (2024). Frequency and severity of hyponatremia in healthy children with acute illness. Pediatric Nephrology. 40(3). 765–772.
5.
Hayashi, Hiroshi, et al.. (2023). Association of Yersinia Infection With Kawasaki Disease: A Prospective Multicenter Cohort Study. The Pediatric Infectious Disease Journal. 42(12). 1041–1044. 2 indexed citations
6.
Hataya, Hiroshi, et al.. (2023). Viral loads of parainfluenza virus type 3 and severity of respiratory diseases in children. Journal of Infection and Chemotherapy. 29(7). 678–682. 3 indexed citations
7.
Ranchin, Bruno, Claus Peter Schmitt, Bradley A. Warady, et al.. (2023). Devices for long-term hemodialysis in small children—a plea for action. Kidney International. 103(6). 1038–1040. 9 indexed citations
8.
9.
Hayashi, Hiroshi, et al.. (2022). Sjögren's syndrome in a 7‐year‐old boy with fever of unknown origin. Journal of Paediatrics and Child Health. 58(12). 2316–2318.
10.
Hamada, Riku, Ryoko Harada, Yuko Hamasaki, et al.. (2022). Factors related to ultrafiltration volume with icodextrin dialysate use in children. Pediatric Nephrology. 38(4). 1267–1273. 2 indexed citations
11.
Okazaki, Kaoru, et al.. (2021). Evaluation of the accuracy of a non-invasive hemoglobin-monitoring device in schoolchildren. Pediatrics & Neonatology. 63(1). 19–24. 8 indexed citations
12.
Okuda, Yusuke, Riku Hamada, Osamu Uemura, et al.. (2021). Mean of creatinine clearance and urea clearance examined over 1 h estimates glomerular filtration rate accurately and precisely in children. Nephrology. 26(10). 763–771. 3 indexed citations
13.
Miura, Kenichiro, Shoichiro Kanda, Taeko Hashimoto, et al.. (2021). Response to steroid and immunosuppressive therapies may predict post‐transplant recurrence of steroid‐resistant nephrotic syndrome. Pediatric Transplantation. 26(8). e14103–e14103. 2 indexed citations
14.
Gotoh, Yoshimitsu, Seiichiro Shishido, Yuko Hamasaki, et al.. (2020). Kidney function of Japanese children undergoing kidney transplant with preemptive therapy for cytomegalovirus infection. Transplant Infectious Disease. 22(3). e13271–e13271. 3 indexed citations
15.
Okamoto, Keisuke, Tomohiro Morio, Yoshikazu Nakamura, et al.. (2020). Hospitalisations due to respiratory syncytial virus infection in children with Down syndrome before and after palivizumab recommendation in Japan. Acta Paediatrica. 110(4). 1299–1306. 5 indexed citations
16.
Morizawa, Yosuke, Hiroyuki Satoh, Atsuko Sato, et al.. (2020). Increasing bladder capacity and vesicoureteral reflux in pediatric kidney transplant patients. International Journal of Urology. 27(11). 1008–1012. 1 indexed citations
17.
Asanuma, Hiroshi, et al.. (2017). Epstein-Barr virus-associated myelitis in a child receiving immunosuppressive therapy. 49(4). 279–282.
18.
Kagami, Shoji, Hirokazu Okada, Shinya Kaname, et al.. (2012). [Diagnostic criteria of atypical hemolytic uremic syndrome].. PubMed. 2(2). 91–3. 3 indexed citations
19.
Ikezumi, Yohei, Masataka Honda, Takeshi Matsuyama, et al.. (2012). Establishment of a normal reference value for serum β2 microglobulin in Japanese children: reevaluation of its clinical usefulness. Clinical and Experimental Nephrology. 17(1). 99–105. 11 indexed citations
20.
Ikeda, Masahiro, et al.. (2001). Reversible posterior leukoencephalopathy in a patient with minimal-change nephrotic syndrome. American Journal of Kidney Diseases. 37(4). e30.1–e30.3. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jayanthi Chandar Breakdown of academic impact, for papers by Sanjeev Gulati Breakdown of academic impact, for papers by Gastón Zilleruelo Breakdown of academic impact, for papers by Frank Martinez Breakdown of academic impact, for papers by Hüseyin Töz Breakdown of academic impact, for papers by Paul T. McEnery Breakdown of academic impact, for papers by Aydın Türkmen Breakdown of academic impact, for papers by C. Frederic Strife Breakdown of academic impact, for papers by Ziad Zoghby Breakdown of academic impact, for papers by Oğuz Söylemezoğlu
Rankless by CCL
2026